Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Venture Life ( (GB:VLG) ) just unveiled an update.
Venture Life Group has repurchased 47,051 of its own ordinary shares at a volume-weighted average price of 70.94 pence under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 4,999,288 are held in treasury, leaving 123,860,857 voting rights, a change that may affect shareholder notification thresholds under FCA rules.
The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.
Spark’s Take on GB:VLG Stock
According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.
Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.
To see Spark’s full report on GB:VLG stock, click here.
More about Venture Life
Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. Its portfolio spans women’s intimate healthcare, ENT care, energy and glucose management, and products supporting the hormonal lifecycle, sold via pharmacies, health and beauty retailers, grocery chains, and e-commerce, both directly and through international distributors.
Average Trading Volume: 277,169
Technical Sentiment Signal: Buy
Current Market Cap: £87.37M
For an in-depth examination of VLG stock, go to TipRanks’ Overview page.

